# Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension

> **NCT02755259** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Zurich** · enrollment: 33 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02755259
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2019-04-05
- **Final completion:** 2019-04-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02755259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02755259, "Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02755259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*